pubmed-article:10821781 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10821781 | lifeskim:mentions | umls-concept:C0036751 | lld:lifeskim |
pubmed-article:10821781 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:10821781 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
pubmed-article:10821781 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:10821781 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:10821781 | pubmed:dateCreated | 2000-8-1 | lld:pubmed |
pubmed-article:10821781 | pubmed:abstractText | The novel 5-HT(7) receptor antagonist, SB-269970-A, potently displaced [(3)H]-5-CT from human 5-HT(7(a)) (pK(i) 8.9+/-0.1) and 5-HT(7) receptors in guinea-pig cortex (pK(i) 8.3+/-0.2). 5-CT stimulated adenylyl cyclase activity in 5-HT(7(a))/HEK293 membranes (pEC(50) 7.5+/-0.1) and SB-269970-A (0.03 - 1 microM) inhibited the 5-CT concentration-response with no significant alteration in the maximal response. The pA(2) (8.5+/-0.2) for SB-269970-A agreed well with the pK(i) determined from [(3)H]-5-CT binding studies. 5-CT-stimulated adenylyl cyclase activity in guinea-pig hippocampal membranes (pEC(50) of 8.4+/-0.2) was inhibited by SB-269970-A (0.3 microM) with a pK(B) (8.3+/-0.1) in good agreement with its antagonist potency at the human cloned 5-HT(7(a)) receptor and its binding affinity at guinea-pig cortical membranes. 5-HT(7) receptor mRNA was highly expressed in human hypothalamus, amygdala, thalamus, hippocampus and testis. SB-269970-A was CNS penetrant (steady-state brain : blood ratio of ca. 0.83 : 1 in rats) but was rapidly cleared from the blood (CLb=ca. 140 ml min(-1) kg(-1)). Following a single dose (3 mg kg(-1)) SB-269970 was detectable in rat brain at 30 (87 nM) and 60 min (58 nM). In guinea-pigs, brain levels averaged 31 and 51 nM respectively at 30 and 60 min after dosing, although the compound was undetectable in one of the three animals tested. 5-CT (0.3 mg kg(-1) i.p.) induced hypothermia in guinea-pigs was blocked by SB-269970-A (ED(50) 2.96 mg kg(-1) i.p.) and the non-selective 5-HT(7) receptor antagonist metergoline (0.3 - 3 mg kg(-1) s.c.), suggesting a role for 5-HT(7) receptor stimulation in 5-CT induced hypothermia in guinea-pigs. SB-269970-A (30 mg kg(-1)) administered at the start of the sleep period, significantly reduced time spent in Paradoxical Sleep (PS) during the first 3 h of EEG recording in conscious rats. | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:language | eng | lld:pubmed |
pubmed-article:10821781 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10821781 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10821781 | pubmed:month | Jun | lld:pubmed |
pubmed-article:10821781 | pubmed:issn | 0007-1188 | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:MiddlemissD... | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:RileyG JGJ | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:SteadBB | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:ThomasD RDR | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:SmithM IMI | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:HaganJ JJJ | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:UptonNN | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:PriceG WGW | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:JeffreyPP | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:MedhurstA DAD | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:PiperDD | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:DeeksN JNJ | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:BromidgeS MSM | lld:pubmed |
pubmed-article:10821781 | pubmed:author | pubmed-author:LovellP JPJ | lld:pubmed |
pubmed-article:10821781 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10821781 | pubmed:volume | 130 | lld:pubmed |
pubmed-article:10821781 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10821781 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10821781 | pubmed:pagination | 539-48 | lld:pubmed |
pubmed-article:10821781 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:meshHeading | pubmed-meshheading:10821781... | lld:pubmed |
pubmed-article:10821781 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10821781 | pubmed:articleTitle | Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. | lld:pubmed |
pubmed-article:10821781 | pubmed:affiliation | Neuroscience Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW. | lld:pubmed |
pubmed-article:10821781 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10821781 | lld:pubmed |